Amarin Corp PLC
AMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000897448
No open-market purchases or sales by Amarin Corp PLC insiders were filed in the last 90 days; 80 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Amarin Corp PLC insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Amarin Corp PLC, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Fishman Peter L. | SVP, CFO | 7,619 | Aug 3, 2026 | 5 |
| Keenan David Paul | EVP, Chief Operating Officer | 13,470 | Jul 15, 2026 | 3 |
| Ketchum Steven B | EVP, Chief Scientific Officer | 42,680 | Jul 15, 2026 | 3 |
| Provoost Jonathan | EVP, Chief Legal Officer | 4,624 | Jul 15, 2026 | 3 |
| Berg Aaron | President and CEO | 85,648 | Jun 30, 2026 | 2 |
| Bonfiglio Patrice Eadon | Director | 836 | Apr 22, 2026 | 1 |
| Odysseas Kostas D | Director | 836 | Apr 21, 2026 | 1 |
| Horn Keith | Director | 836 | Apr 21, 2026 | 1 |
| Sterling Louis III | Director | 4,049 | Apr 21, 2026 | 1 |
| Sullivan Diane E. | Director | 836 | Apr 21, 2026 | 1 |
| Cohen Paul | Director | 836 | Apr 21, 2026 | 1 |
| O'Connor Oliver | Director | 801 | Apr 21, 2026 | 1 |
| DiPaolo Mark | Director | 401 | Apr 22, 2025 | 0 |
| Reilly Thomas Charles | EVP and CFO | 94,305 | Jul 1, 2024 | 0 |
| Holt Patrick | President and CEO | 314,426 | Jan 24, 2024 | 0 |
| Wold Olsen Per | Director | 171,027 | Feb 23, 2023 | 0 |
| Mikhail Karim | President and CEO | 283,507 | Feb 23, 2023 | 0 |
| Stewart Murray | Director | – | Jan 12, 2023 | 0 |
| Murphy Geraldine | Director | – | Nov 2, 2022 | 0 |
| Berger Adam Mark | Director | – | Nov 2, 2022 | 0 |
| Marks Jason M. | EVP,Chief Global Legal Officer | 21,917 | Aug 23, 2022 | 0 |
| Kalb Michael Wayne | SVP and CFO | 337,314 | Aug 2, 2022 | 0 |
| Van Heek G Jan | Director | – | Jun 29, 2022 | 0 |
| Ekman Lars | Director | – | Jun 29, 2022 | 0 |
| O'Sullivan Patrick J | Director | – | Jun 29, 2022 | 0 |
| Peterson Kristine | Director | – | Jun 29, 2022 | 0 |
| Enright Erin S. | Director | – | Jun 29, 2022 | 0 |
| Zulueta Alfonso G | Director | – | Jun 29, 2022 | 0 |
| Zakrzewski Joseph S | Director | 196,547 | Dec 16, 2021 | 0 |
| Thero John F | President and CEO | 3,252,752 | Aug 3, 2021 | 0 |
| Kennedy Joseph T | General Counsel | 317,860 | Aug 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 (view filing) | Aug 2 | 3 days | Berg AaronPresident and CEO | PPurchase | +160.0K | $0.64 | +$102.4K | +24.8%805.4K after | |
| Jan 24, 2024 (view filing) | Jan 22 | 2 days | Holt PatrickPresident and CEO | PPurchase | +14.4K | $1.09 | +$15.7K | +4.8%314.4K after | |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Ketchum Steven BChief Scientific Officer | SSale | −34.1K | $0.79 | −$27.0K | −5.7%566.1K after | 10b5-1 |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Holt PatrickPresident and CEO | PPurchase | +300.0K | $1.04 | +$312.5K | New position300.0K after | 7 lots |
| Jun 15, 2022 (view filing) | Jun 13 | 2 days | Wold Olsen PerDirector | PPurchase | +55.0K | $1.69 | +$93.0K | +58.5%149.0K after | |
| Dec 16, 2021 (view filing) | Dec 14-15 | 2 days | Zakrzewski Joseph SDirector | PPurchase | +12.0K | $3.25 | +$39.0K | +6.5%196.5K after | 2 lots |
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Kalb Michael WayneSVP and CFO | SSale | −120.0K | $5.25 | −$630.0K | −36.9%205.0K after |